Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.
Tentang
Health Technology
Pharmaceuticals: Generic
Manufacturing
Pharmaceutical Preparation Manufacturing
Kindred Biosciences, Inc., a biopharmaceutical company, is developing biologics that focus on the lives of pets. The company has a pipeline of novel biologics in development across various therapeutic classes and intellectual property portfolio. Its programs under development include interleukin-31 and interleukin-4R for canine atopic dermatitis; KIND-030 for parvovirus in dogs; KIND-510a for the control of non-regenerative anemia in cats; anti-TNF antibody for inflammatory bowel disease in dogs; and other biologics candidates. The company was founded in 2012 and is headquartered in Burlingame, California.
Show more...
CEO
Richard Chin
Karyawan
63
Negara
US
Pencatatan
0 Comments
Bagikan pendapatmu
FAQ
Berapa harga saham Kindred Biosciences hari ini?▼
Harga saat ini dari KIN adalah $9.25 USD — naik sebesar +0.11% dalam 24 jam terakhir. Pantau kinerja harga saham Kindred Biosciences lebih dekat di grafik.
Apa simbol saham Kindred Biosciences?▼
Tergantung pada bursa, simbol saham dapat berbeda. Misalnya, di bursa , saham Kindred Biosciences diperdagangkan dengan simbol KIN.
Berapa kapitalisasi pasar Kindred Biosciences?▼
Hari ini Kindred Biosciences memiliki kapitalisasi pasar sebesar 420.53M
Berapa jumlah karyawan Kindred Biosciences?▼
Per April 02, 2026, perusahaan memiliki 63 karyawan.
Kindred Biosciences berada di sektor apa?▼
Kindred Biosciences beroperasi di sektor Manufacturing.